Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 158

1.

CTLA-4-mediated inhibition in regulation of T cell responses: mechanisms and manipulation in tumor immunotherapy.

Chambers CA, Kuhns MS, Egen JG, Allison JP.

Annu Rev Immunol. 2001;19:565-94. Review.

PMID:
11244047
2.

The role of CTLA-4 in induction and maintenance of peripheral T cell tolerance.

Eagar TN, Karandikar NJ, Bluestone JA, Miller SD.

Eur J Immunol. 2002 Apr;32(4):972-81.

3.

CTLA-4: new insights into its biological function and use in tumor immunotherapy.

Egen JG, Kuhns MS, Allison JP.

Nat Immunol. 2002 Jul;3(7):611-8. Review.

PMID:
12087419
4.

Lymphoproliferative disorder in CTLA-4 knockout mice is characterized by CD28-regulated activation of Th2 responses.

Khattri R, Auger JA, Griffin MD, Sharpe AH, Bluestone JA.

J Immunol. 1999 May 15;162(10):5784-91.

5.

Signaling through CD28 and CTLA-4 controls two distinct forms of T cell anergy.

Wells AD, Walsh MC, Bluestone JA, Turka LA.

J Clin Invest. 2001 Sep;108(6):895-903.

6.

Costimulatory regulation of T cell function.

Chambers CA, Allison JP.

Curr Opin Cell Biol. 1999 Apr;11(2):203-10. Review.

PMID:
10209159
7.

Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation.

Salomon B, Bluestone JA.

Annu Rev Immunol. 2001;19:225-52. Review.

PMID:
11244036
8.

Antigen-dependent clonal expansion of a trace population of antigen-specific CD4+ T cells in vivo is dependent on CD28 costimulation and inhibited by CTLA-4.

Kearney ER, Walunas TL, Karr RW, Morton PA, Loh DY, Bluestone JA, Jenkins MK.

J Immunol. 1995 Aug 1;155(3):1032-6.

PMID:
7543510
9.

Expression and functional significance of CTLA-4, a negative regulator of T cell activation.

Kosmaczewska A, Ciszak L, Boćko D, Frydecka I.

Arch Immunol Ther Exp (Warsz). 2001;49(1):39-46. Review.

PMID:
11266089
10.

Manipulation of T cell costimulatory and inhibitory signals for immunotherapy of prostate cancer.

Kwon ED, Hurwitz AA, Foster BA, Madias C, Feldhaus AL, Greenberg NM, Burg MB, Allison JP.

Proc Natl Acad Sci U S A. 1997 Jul 22;94(15):8099-103.

11.

Blockade of T cell activation using a surface-linked single-chain antibody to CTLA-4 (CD152).

Griffin MD, Hong DK, Holman PO, Lee KM, Whitters MJ, O'Herrin SM, Fallarino F, Collins M, Segal DM, Gajewski TF, Kranz DM, Bluestone JA.

J Immunol. 2000 May 1;164(9):4433-42.

12.

Differential role of CTLA-4 in regulation of resting memory versus naive CD4 T cell activation.

Metz DP, Farber DL, Taylor T, Bottomly K.

J Immunol. 1998 Dec 1;161(11):5855-61.

13.

Role of the B7-CD28/CTLA-4 pathway in autoimmune disease.

Chang TT, Kuchroo VK, Sharpe AH.

Curr Dir Autoimmun. 2002;5:113-30. Review. No abstract available.

PMID:
11826754
14.

B7 interactions with CD28 and CTLA-4 control tolerance or induction of mucosal inflammation in chronic experimental colitis.

Liu Z, Geboes K, Hellings P, Maerten P, Heremans H, Vandenberghe P, Boon L, van Kooten P, Rutgeerts P, Ceuppens JL.

J Immunol. 2001 Aug 1;167(3):1830-8.

15.

The role of CTLA-4 in the regulation of T cell immune responses.

McCoy KD, Le Gros G.

Immunol Cell Biol. 1999 Feb;77(1):1-10. Review.

16.

Costimulation and its role in organ transplantation.

Bluestone JA.

Clin Transplant. 1996 Feb;10(1 Pt 2):104-9. Review.

PMID:
8680045
17.

Role of B7:CD28/CTLA-4 in the induction of chronic relapsing experimental allergic encephalomyelitis.

Perrin PJ, Scott D, Quigley L, Albert PS, Feder O, Gray GS, Abe R, June CH, Racke MK.

J Immunol. 1995 Feb 1;154(3):1481-90.

PMID:
7529805
18.
19.

Tyrosine-mediated inhibitory signals contribute to CTLA-4 function in vivo.

Yi LA, Hajialiasgar S, Chuang E.

Int Immunol. 2004 Apr;16(4):539-47.

20.

The expanding B7 superfamily: increasing complexity in costimulatory signals regulating T cell function.

Coyle AJ, Gutierrez-Ramos JC.

Nat Immunol. 2001 Mar;2(3):203-9. Review.

PMID:
11224518
Items per page

Supplemental Content

Write to the Help Desk